Literature DB >> 2800911

IgE antibody to sweat in atopic dermatitis.

K Adachi1, T Aoki.   

Abstract

Of 45 patients with atopic dermatitis skin-tested with their own sweat, 43 showed positive immediate-type skin reactions to titres between 1 and 256. Of 22 non-atopic patients 18 showed negative reactions. Skin reactivity of the atopic patients to the sweat and house dust did not run parallel. Radioallergosorbent test (RAST) using the sweat collected from a healthy subject detected IgE antibody in 24 atopic patients with a score from 0.5 to 3.5, whereas all the control subjects showed the score 0. This IgE antibody to sweat did not cross-react with the mite extract (Dermatophagoides farinae) or Staphylococcus aureus. These results indicate that atopic patients have specific IgE antibody to sweat.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2800911

Source DB:  PubMed          Journal:  Acta Derm Venereol Suppl (Stockh)        ISSN: 0365-8341


  4 in total

1.  Immunological Changes of Basophil Hyperreactivity to Sweat in Patients With Well-Controlled Atopic Dermatitis.

Authors:  Tomofumi Numata; Shunsuke Takahagi; Kaori Ishii; Satoshi Morioke; Takanobu Kan; Hayato Mizuno; Yuhki Yanase; Tomoko Kawaguchi; Akio Tanaka; Michihiro Hide
Journal:  Front Immunol       Date:  2022-06-29       Impact factor: 8.786

Review 2.  New concepts of hive formation in cholinergic urticaria.

Authors:  Tastuya Horikawa; Atsushi Fukunaga; Chikako Nishigori
Journal:  Curr Allergy Asthma Rep       Date:  2009-07       Impact factor: 4.806

3.  Usefulness of Sweat Management for Patients with Adult Atopic Dermatitis, regardless of Sweat Allergy: A Pilot Study.

Authors:  Sakae Kaneko; Hiroyuki Murota; Susumu Murata; Ichiro Katayama; Eishin Morita
Journal:  Biomed Res Int       Date:  2017-01-22       Impact factor: 3.411

Review 4.  Cholinergic Urticaria: Subtype Classification and Clinical Approach.

Authors:  Atsushi Fukunaga; Yoshiko Oda; Shinya Imamura; Mayuko Mizuno; Takeshi Fukumoto; Ken Washio
Journal:  Am J Clin Dermatol       Date:  2022-09-15       Impact factor: 6.233

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.